Navigation Links
ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom(TM) 0.09%
Date:12/4/2008

product in the U.S. in 2005. According to IMS data, Xibrom was the fastest-growing branded ophthalmic product (with sales greater than $10 million) in the nine-month period ended September 2008.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion. U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.

Any statements contained in this press release which refer to future events or other non-historical matters are forward-looking statements. Without limiting the foregoing, but by way of example, statements contained in this press release related to planning to conduct a confirmatory Phase III trial for Xibrom and expecting to complete such trial in 2009, ISTA's expectation of bringing a new product to market every 12 to 18 months and becoming the leading niche ophthalmic pharmaceutical company are forward-looking statements. Except as required by law, ISTA disclaims any intent or obligation to update any forward-looking statements. These forward-looking statements are based on ISTA's expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially. Important factors that could cause actual results to differ from current expectations include, a
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology
2. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
3. Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
4. Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia
5. Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia
6. Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351
7. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
8. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
9. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
10. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
11. Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... NEW YORK , April 17, 2015  Over the ... expected to continue to grow, with ArcView predicting that 14 ... will legalize medical marijuana. The U.S. market for legal cannabis ... $1.5 billion in 2013. Analysts project the market could grow ... years, assuming more states soften their stance on marijuana. ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/7qs3dw/corporate ... Reputation of Pharma in 2014 - a Perspective of ... their offering. This independent study, funded by ... with an interest in diabetes on the corporate reputation ... industry as a whole) in 2014. The results from ...
(Date:4/17/2015)... DUBLIN , Apr. 16, 2015 Research and ... addition of the "Corporate Reputation of Pharma in ... - 1st Edition" report to their offering. ... has compared opinions on the corporate reputation of the ... in mental health with the views of patient organisations ...
Breaking Medicine Technology:Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3
... Solutions Development Company (MSDC), www.msdrx.com , will present ... Diabetes (EASD) annual conference in Stockholm, Sweden on Sept. ... candidate, MSDC-0160, promotes the proliferation of stem cells that ... brown fat.  The research was conducted in tissue cultures ...
... Canon Communications LLC today announced that it ... Limited, a leading global business media company.  The agreement ... company of Canon Chairman and CEO Charles G. McCurdy, and ... and Spectrum acquired Canon in 2005. "The last ...
Cached Medicine Technology:Metabolic Solutions Development Company to Present Research Findings to European Association for the Study of Diabetes 2Canon Communications to be Sold to United Business Media; Transaction Expands Global Reach of Canon's Advanced Manufacturing and Design Focus 2Canon Communications to be Sold to United Business Media; Transaction Expands Global Reach of Canon's Advanced Manufacturing and Design Focus 3
(Date:4/18/2015)... April 18, 2015 "I recognized the ... in healthcare facilities," said an inventor from Cincinnati, Ohio. ... system." , He developed the Slyde Door to offer ... in healthcare facilities. It provides convenient storage space for ... more stretchers available for patients. , This offers ...
(Date:4/18/2015)... Lower-auto-insurance.com has released a new blog ... insurance quotes . , Drivers can find accurate ... A professional insurance brokerage website can help drivers compare ... simple, convenient way. The whole process is designed to ... Comparing online car insurance quotes is advantageous because it ...
(Date:4/18/2015)... York, NY (PRWEB) April 18, 2015 On ... Internal Security Threat Report , which they say, “exposes a ... how many new malware variants were introduced in 2014 - ... took for Zero Day threats to be identified and patched ... it is abundantly clear that doing business in a digital ...
(Date:4/17/2015)... (PRWEB) April 18, 2015 Heritage Woods ... begin its Supportive Living Week Celebration on April 20 ... having a healthy mind, body and soul. , The ... McLeansboro, Illinois, serves older adults of all incomes, including ... their independence. , Supportive Living Week is observed every ...
(Date:4/17/2015)... Oklahoma (PRWEB) April 17, 2015 Alcohol ... Drug Dependence (NCADD) notes that drinking and driving has ... At the same time, the link between alcohol ... as domestic abuse and violence and sexual assault, and ... According to the NCADD, 5.3 million adults in America ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3
... able to reverse some of the damage to their lungs ... according to research out of the University of Groningen in ... December 15 issue of the American Thoracic Society,s American ... found that exposure to cigarette smoke appears to increase the ...
... , Consumers advised to ... Md., Dec. 6 The U.S. Food and Drug Administration is ... Bay on or after Nov. 16 due to reports of norovirus-associated ... area, which is located on the Gulf of Texas. , ...
... for future treatments targeting growth factor, researchers say , ... cancer cells from the main tumor to other parts of ... TGFb, which may prove a promising target for new drugs ... studies have shown that TGFb (transforming growth factor beta) regulates ...
... , NEW ORLEANS, Dec. 6 Onyx ... data from the pivotal Phase 2b 003-A1 study, known as ... pre-treated relapsed and refractory multiple myeloma patients. These data were ... annual meeting of the American Society of Hematology (ASH) in ...
... A new study provides welcome news for patients with a ... The condition is estimated to impact 62,000 Canadians and half-a-million ... in a vein and restricts the flow of blood, causing ... from its point of origin and travel through the heart ...
... Attorney ... been found in toys in past holiday seasons. , ... New York, NY (PRWEB) December 6, 2009 -- As parents shop ... due to lead paint or asbestos contamination, says a New York personal injury lawyer., , ...
Cached Medicine News:Health News:Quitting smoking can reverse asthma-inducing changes in lungs 2Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:Breast Cancer's Spread Now Better Understood 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3
... Codman ICP Monitoring System ... of intracranial pressure at ... intraventricular levels. The information ... than through a hydrostatic ...
The Optical Tracking System provides a complete solution for image-guided surgery. Precision tracking technology converges with powerful visualization software for optimal surgical planning and navig...
Penfield Dissector #4...
Leroy-Raney scalp clips, sterile, disposable, plastic, ten clips/package....
Medicine Products: